These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2596471

  • 1. Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
    Donadio JV, Offord KP.
    Am J Kidney Dis; 1989 Dec; 14(6):445-51. PubMed ID: 2596471
    [Abstract] [Full Text] [Related]

  • 2. Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS).
    Zäuner I, Böhler J, Braun N, Grupp C, Heering P, Schollmeyer P.
    Nephrol Dial Transplant; 1994 Dec; 9(6):619-22. PubMed ID: 7970086
    [Abstract] [Full Text] [Related]

  • 3. Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989.
    McEnery PT.
    J Pediatr; 1990 May; 116(5):S109-14. PubMed ID: 2329412
    [Abstract] [Full Text] [Related]

  • 4. Results of a controlled drug trial in membranoproliferative glomerulonephritis.
    Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN.
    Kidney Int; 1985 Feb; 27(2):436-41. PubMed ID: 3886998
    [Abstract] [Full Text] [Related]

  • 5. Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?
    Somers M, Kertesz S, Rosen S, Herrin J, Colvin R, Palacios de Carreta N, Kim M.
    Pediatr Nephrol; 1995 Apr; 9(2):140-4. PubMed ID: 7794705
    [Abstract] [Full Text] [Related]

  • 6. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature.
    D'Amico G.
    Am J Kidney Dis; 1992 Oct; 20(4):315-23. PubMed ID: 1415198
    [Abstract] [Full Text] [Related]

  • 7. Childhood membranoproliferative glomerulonephritis: an approach to management.
    West CD.
    Kidney Int; 1986 May; 29(5):1077-93. PubMed ID: 3523004
    [No Abstract] [Full Text] [Related]

  • 8. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH.
    N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535
    [Abstract] [Full Text] [Related]

  • 9. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U.
    Am J Med; 1983 Dec 31; 75(6):920-7. PubMed ID: 6359877
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1992 May 31; 37(5):229-34. PubMed ID: 1606772
    [Abstract] [Full Text] [Related]

  • 11. [Effect of ligustrazine on proliferative glomerulonephritis].
    Tang X.
    Zhong Yao Cai; 2003 Aug 31; 26(8):611-2. PubMed ID: 14649206
    [Abstract] [Full Text] [Related]

  • 12. Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.
    Takeda A, Niimura F, Matsutani H.
    Nihon Jinzo Gakkai Shi; 1995 Jun 31; 37(6):330-5. PubMed ID: 7666598
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
    Knotková V, Petrů I, Nĕmecek K, Cieslar P, Pelèska J, Jáchymová M, Pick P, Tomasy M.
    Cas Lek Cesk; 1989 Jun 28; 128(26):814-8. PubMed ID: 2507156
    [Abstract] [Full Text] [Related]

  • 14. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ, Cameron JS, Chantler C, Turner D.
    Arch Dis Child; 1980 Jun 28; 55(6):446-51. PubMed ID: 7436483
    [Abstract] [Full Text] [Related]

  • 15. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
    Inaba S, Tanizawa T, Takahashi T, Ishihara S, Arai M, Sakai Y, Kurose KK, Matsukura H, Okada T.
    Clin Nephrol; 1996 Apr 28; 45(4):217-25. PubMed ID: 8861795
    [Abstract] [Full Text] [Related]

  • 16. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb 28; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine in the treatment of membranoproliferative glomerulonephritis.
    Bagheri N, Nemati E, Rahbar K, Nobakht A, Einollahi B, Taheri S.
    Arch Iran Med; 2008 Jan 28; 11(1):26-9. PubMed ID: 18154419
    [Abstract] [Full Text] [Related]

  • 18. The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.
    McEnery PT, McAdams AJ, West CD.
    Medicine (Baltimore); 1985 Nov 28; 64(6):401-24. PubMed ID: 2414636
    [Abstract] [Full Text] [Related]

  • 19. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E, Sinn W, Lakner V, Ratner M, Tomilina N.
    Z Gesamte Inn Med; 1980 Aug 01; 35(15):Suppl 45-8. PubMed ID: 7467565
    [Abstract] [Full Text] [Related]

  • 20. Type of immune and complement deposits and response of immunosuppressive treatment on Membranoproliferative Glomerulonephritis -- a single centre experience.
    Imtiaz S, Dhrolia MF, Nasir K, Salman B, Ahmad A.
    J Pak Med Assoc; 2015 Sep 01; 65(9):995-1000. PubMed ID: 26338748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.